Crossing the next frontier, to give you a fair chance to fight Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation immunotherapies in immuno-oncology and immuno-inflammation. Our novel candidates harness microbiome-associated innate immune regulatory mechanisms. Inflammatory Bowel Diseases, Live Biotherapeutics, Microbiome, Immunotherapies, Immuno-oncology, and Immuno-inflammation

101 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Adding Quality Years of Life We are dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

207 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

See Nature Differently Through pioneering life science and artificial intelligence, we developed our unique Nuritas MagnifierNπΦ platform that allows us to identify, unlock, clinically test and patent peptides; turning them into powerful and precise ingredients that elevate natural efficacy. We want to empower people to live healthier lives, naturally by making our everyday products healthier, safer, greener and more efficacious. From what we eat, to what we apply to our skin. By translating nature’s wisdom into innovation, together, we can change the life of billions. Pure peptides, Peptide mixtures, Hydrolysates, Multi targeted peptides, Bioinformatics, Artificial intelligence for drug discovery, Peptide …

58 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology

Leading biotech in the development of innovative microbiome-based biotherapies YSOPIA Bioscience is a clinical-stage biotech company developing cutting-edge biotherapies based on the gut microbiome. Our goal is to bring safe & efficient solutions to patients with high unmet medical needs. Microbiome, Obesity, Gut modulator, Cardiometabolism, Cardiometabolic diseases, Microbiota, and Gut microbiota

200 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Innovation in healthcare solutions. We are an industry leader in the medical device market with a diverse product range including advanced automatic injection devices for drug delivery and innovative blood sampling products including lancets, lancing devices and safety lancets. Established in 1952 by Ivan Owen and John Mumford, we have 70 years of experience with offices, manufacturing sites and distributors located around the globe. Our corporate headquarters are located in Woodstock, Oxford UK. We are dedicated to providing innovative healthcare solutions for the management of a variety of medical conditions. With one of the most advanced global research, design and …

23 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

A thriving life science community for entrepreneurs and leaders and the ideal environment for businesses to succeed 🧪 Discovery Park is the ideal environment for life science businesses to succeed. From state-of-the-art labs and offices to comprehensive support, we work in partnership with you to provide firm foundations for every stage of your growth. Within easy reach of London, our location provides access to a wealth of resources and opportunities with the freedom to expand, making it the optimal setting for brilliant minds to unlock the potential of scientific breakthroughs. Science, Technology, Manufacturing, Research , Research and Development, Enterprise, Logistics, …

75 similar entities Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology

Make​ your Own Neuronal Network At MicroBrain Biotech, our mission is to revolutionize drug development by embracing ethical and cruelty-free practices, putting humanity at the center of our work, and relentlessly pursuing groundbreaking discoveries. We are committed to creating innovative solutions that improve the quality of life for patients and their families, while treating all living beings with compassion and respect. Through collaboration, scientific excellence, and a commitment to sustainability, we aim to leave a lasting positive impact on the world of healthcare and beyond.

Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

FOR ANIMALS. FOR HEALTH. FOR YOU. Zoetis is a global animal health company dedicated to supporting our customers and their businesses in ever-better ways. Building on 60 years of experience, we deliver high-quality medicines, vaccines, support and education. Every day, we work to better understand and address the real-world challenges faced by the people who own and care for animals, in ways that matter most to them.

21 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Life-Transforming Medicines for Patients Living with Serious Rare Diseases VectivBio AG is a clinical-stage biotechnology company focused on rare diseases with a well-defined biology that can be targeted with transformational therapeutics. VectivBio was formed in 2019 as a spinout from Therachon, a biotechnology company acquired by Pfizer, Inc., for its program in achondroplasia, with the ambition to continue to have an impact on people’s lives by bringing transformational medicines to patients with serious rare conditions. The company is led by a world-class leadership team with deep expertise in rare diseases and a track record of success in R&D, commercialization and …

104 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Facilitators of Life Sciences Research We facilitate Life Sciences Research every day, contributing to advance Science for a brighter future. Through our local offices located across Europe, we support Life Sciences and Biotechnology Researchers with a unique, holistic range of solutions to advance their projects faster:​ - We enable researchers to be at the forefront in their Research with access to cutting-edge biological solutions sourced from reputed global Life Sciences suppliers, carefully selected by our Scientific Team for their relevance and evaluated for their ethical and legal compliance. ​ - We accelerate their Research thanks to our Contract Research Services’ …

102 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Healthcare & Life Sciences communication agency Panacee is a communication agency specialized in health market. We deal with the main stakeholders of life sciences and medical area; #biotech, #medtech, #mhealth, #publichealth, #pharma Communication, Marketing, Santé, Scientifique, Sciences de la vie, Médical, Biotech, medtech, pharma, medical devices, Santé publique, identité visuelle, Digital, Print, réseaux sociaux, BtoB, professionnels de santé, chercheurs, and patients

150 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

TAKING CARE TO Heart Through its subsidiaries, Mayoly is a family-owned, independent, french pharmaceutical and dermatological laboratory with an international footprint. For More than a Century, it has successfully been growing its business with a focus on gastroenterology and dermocosmetics. Our French Industrial Heritage Related on Values ​​of Responsibility, Pragmatism and Caring. We Strive Passionately and Tirelessly to Provide Patients and People With the Best possible Healthcare Daily, and Aim to Establish Ourselves as a Leader in Consumer Healthcare Over the Coming Decades Our know-how applies to several therapeutic areas, such as gastroenterology, rheumatology, ENT, general medicine or even consumer …

9 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Helping you achieve positive outcomes for your patients The world needs you at your best, so we create breakthrough solutions that help you save valuable time and restore patients' lives. Medical products and solutions, Dental and orthodontic supplies, and Health information solutions

174 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Better Medicine For All Better Medicine for All MedinCell is a pharmaceutical company at commercial stage. We develop a portfolio of long-acting injectables in various therapeutic areas. Our proprietary technology BEPO® aims to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. We collaborate with tier-one pharmaceutical companies and foundations to improve Global Health through new therapeutic options. Our mission is to contribute to the improvement and protection of the health of populations across the world. The fair sharing of the value created with all our employees is the foundation of our business model. …

73 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Better technology for better health LimmaTech Biologics AG is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. In addition to our proprietary research, we also develop vaccines together with GSK. vaccines, research & development, biotechnology, and antimicrobial resistance

147 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

We represent the innovative pharmaceutical industry globally, with a focus on innovation, equitable access, and ethics. IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere. To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health. Biopharmaceuticals, …

Type: NGO, Think-tanks, Ed, & Culture Startup Activities: biotech deeptech Technologies: Synthetic Biology

Planting the seeds of human health. PLANTING THE SEEDS OF HUMAN HEALTH. First in the world to offer the age-reversing, lifespan and healthspan enhancing Osmotin plant protein product line. Available now in the US and worldwide. Visit www.osmotin.com for more info. biotech, cell life and death cycle, plant biotechnology, human health, age-reversing, and agriculture

61 similar entities Type: Startup Activities: biotech deeptech agritech Technologies: Synthetic Biology

A new generation of vaccines based on fusions of recombinant proteins A new generation of vaccines within animal health We develop vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care, with a very good safety profile. Veterinary, Vaccines, Animal Health, Biotech, Recombinant Vaccines, Veterinary Products, Microbiology, Wholesale, and Research and Development

114 similar entities Type: Startup Activities: manufacturing healthtech deeptech Technologies: Synthetic Biology

We believe in innovation, we seek value, we transform the present. Global project for health development and investment - Healthcare, Biotechnology, Digital Health, Medical Devices, MedTech, e-Health, Health Innovation, Ecosistemas de Innovación, Start Up Salud, Transferencia Tecnología, Agri-Food Tech, Spin Off, and Health Entrepreneurship

89 similar entities Type: SMB Activities: deeptech healthtech

Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases. Biopharmaceutical New Technologies (BioNTech) is a global biotechnology company aspiring to translate science into survival by developing new immunotherapies utilizing the full potential of the immune system to fight cancer and infectious diseases. BioNTech is headquartered in Mainz, Germany, and operates globally with almost 7.000 pioneers. Our work is powered by one mission: Improving the health of people worldwide. We believe that scientific rigor and passion are the driving forces that are essential for innovative progress. BioNTech was founded in …

45 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

We have developed a biological drug SOL-116 for treatment of chronic inflammatory diseases Lipum aims for better quality of life for the millions suffering from chronic inflammatory diseases, including children. Distressed by pain, disability, and comorbidities many have to leave a normal working life in advance. We intend to increase their quality of life and decrease the considerable health care and societal costs. Inflammatory diseases, Drug development, Preclinical research, Blockbuster drugs, Chronic diseases, and Orphan drug designation

46 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

The world's go-to partners for infectious disease biomaterials and testing services. We are the world’s leading experts and go-to collaborators in biological products and services, focused on protecting the health and safety of people around the world. For over 50 years, we have been partnering with healthcare and life science laboratories, manufacturers and suppliers across the globe to co-create and provide biological control materials, assay services and consulting for microbiology, molecular diagnostics and virology. Headquartered in Saint Cloud, Minnesota, we have additional facilities in California, Kentucky and Michigan. Microbiology, Biotechnology, Quality Control, Molecular Microbiology, Contract Research Organization, Virology, Anti-Infective Drug …

175 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Let's Build Better Cells Together We invest in our partners early on, working side by side in optimizing their processes to derisk their path to the clinic faster. Our ExPERTTM platform, which is based on our Flow Electroporation® technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: four instruments, the ATxTM, STxTM, GTxTM and VLx TM; a portfolio of proprietary related processing assemblies or disposables; and software protocols, …

313 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We are a Swiss company on a mission to combat sepsis through magnetic blood purification. Member of @Wyss Zurich. We are a start-up medical device company originating from ETH Zurich and are passionate about developing life saving therapies. Our mission is to develop a breakthrough medical device for the most urgent healthcare issues. Focusing on patients’ needs, we translate the most promising research to the clinics and ensure patient access to scientific progress as soon as possible. As pioneers we take courageous decisions and are shaping the future of medicine. We first focus on finding an efficient therapy for patients …

80 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Expertise that matters Mercodia utilizes its 30+ years of experience as a world-leading manufacturer of cardiometabolic immunoassays to provide tailored bioanalysis solutions for pharma and biotech companies. We specialize in assay development and validation, PK/PD, immunogenicity testing, and biomarker testing, mainly focusing on large molecules, peptides, and oligonucleotide therapeutics in preclinical and clinical development. We are GLP-certified and work in accordance with ICH GCP, EMA, and FDA guidelines. Our team of expert scientists quickly provides reproducible, reliable, and high-quality data that meets regulatory requirements. We prioritize speed and flexibility while delivering cost-effective solutions. Our vision is to improve human health …

140 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

For us, it is all about improving and saving lives. Improving and saving lives through innovative vaccines is at the heart of what we do in Bavarian Nordic, and we have more than 25 years of experience in developing life-saving vaccines. We are a fully integrated vaccine company focused on the development, manufacturing and commercialization of our vaccines. We are a global leader in smallpox and mpox vaccines, which have been developed through our long-standing partnership with the U.S. Government to enhance the public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. Our values …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Dalan's novel platform technology has introduced the world's first-ever honeybee vaccine, marking a pivotal milestone for the industry. Our mission is to safeguard the planet’s most underserved animal species, ensuring their continued well-being for global food security and the overall health of our planet.

60 similar entities Type: Startup Activities: pettech healthtech biotech Technologies: Synthetic Biology

100% Natural Stability For Your Blood Sugar Levels and Weight With science-backed, 100% natural solutions, we empower journeys toward balanced and healthier lives by optimizing metabolism and making well-being achievable every day. prediabetes, diabetes, blood sugar management, healthtech, obesity, innovation, medical device, biotech, and life science

220 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Treating Neurodegenerative Disease by Restoring Autophagy At Samsara Therapeutics, we’re on a mission to unlock the full potential of autophagy activation in combating age-related neurodegenerative diseases. Our innovative approach aims to delay the progression of several debilitating conditions, offering new possibilities for patients and their families. biotechnology, biopharmaceuticals, rare disease, neurodegeneration, longevity, drug discovery, and drug development

159 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Helping health & biotech companies, researchers and entrepreneurs making their projects and dreams come true. GENESIS Biomed is a consultancy firm in the biomedical healthcare sector specialized in providing consulting services in the genesis and first phases of lifecycle of biomedical spin-off and start-up companies, entrepreneurs and research centers. Based in our expertise we help entrepreneurs and researchers to shape their business plan and we support them in the private fundraising process. We have raised 68,5 M€ in the last years in 20 rounds. We are Associate Partner at EIT Health and we are engaged to 23 EU projects with …

52 similar entities Type: SMB Activities: deeptech healthtech consulting entrepreneurship fintech biotech Technologies: A.I.

Pioneering health solutions since 1993. Committed to innovative technology applications in health, we explore Longevity in Japan, delve into Microbiome and Mitochondria research, and contribute to advancements in Anti-Age clinics. Our mission is to empower individuals for a healthy, energetic life.

Type: SMB Activities: deeptech healthtech

Accelerating drug discovery to transform patients' lives Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases

605 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Working to build a health system that is effective, efficient, & driven by a clear vision: patient needs above all else. The Milken Institute's FasterCures believes that transformative and life-saving science should be fully realized and deliver better treatments to the people who need them. biomedical research, R&D collaboration, science policy, venture philanthropy, Partnering for Cures, science communications, medical research, and Health Citizenship

61 similar entities Type: SMB Activities: biotech deeptech

A results-oriented nonprofit dedicated to solving global health issues by forming partnerships with industry. BIO Ventures for Global Health (BVGH) is a Seattle-based nonprofit organization working at the crossroads of the private and public sectors to advance research and improve health. #BVGH #bvghAAI #AC3T BVGH connects people, resources, and ideas across biotechnology and pharmaceutical companies, governments, and nonprofits to solve global health issues. Programmatic activities include accelerating research and development (R&D) for diseases of poverty, expanding access to cancer medicines and technologies in Africa, and building biomedical R&D capacity in low- and middle-income countries (LMICs). global health, Africa, neglected diseases, …

16 similar entities Type: SMB Activities: healthtech biotech deeptech

Genewity is a pioneering biotech start-up focused on advanced thymus-driven therapies for immune reconstitution. Supported by the extensive business expertise of our management and advisors, we are at the forefront of developing and commercialising breakthrough therapies. With over 150 years of combined experience in immunology and gene therapy, our team is uniquely positioned to drive advancements in the field.

275 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Translating science into global health impact. Translating scientific discoveries into affordable, globally accessible public health solutions. IAVI is a non-profit that develops vaccines and antibodies for HIV, tuberculosis, and emerging infectious diseases. AIDS vaccine, research and development, product development partnership, HIV/AIDS, vaccine development, global health, capacity strengthening, clinical trials, and scientific research

59 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

M2Bio Sciences is a pioneering nutraceutical biotech company. Trading on the OTC: $MRES M2Bio Sciences is a pioneering nutraceutical biotechnology company that delves into the innovative realm of plant-based medicines, healthy food products, and sustainable packaging solutions. A distinctive feature of M2Bio Sciences is its divisional structure, each focusing on a specific wellness and sustainability aspect. It is committed to improving both human health and the planet's health. Ethically and sustainably sourced products are central to its mission, reflecting a deep-rooted concern for environmental sustainability. The Company employs cutting-edge artificial intelligence to power its endeavours. Medicine, Biotechnology, Health , Neuroscience, …

41 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I.

Because Patients Can't Wait® As the largest life sciences association in New Jersey, BioNJ is a powerful network of over 400 Member companies representing research-based life sciences companies and stakeholders. Because Patients Can’t Wait®, we are dedicated to propelling the rich innovation ecosystem in the New Jersey region to stimulate and support innovation, improve and save lives, and lower the hurdles of healthcare advancements for society. As the industry’s voice in New Jersey, we fulfill our mission by ensuring that: Science is Supported Companies are Created Drugs are Developed Patients are Paramount Biotechnology, Pharmaceuticals, Life Sciences, New Jersey, Networking, Advocacy, …

74 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Innovation at the service of your health and well-being. Pharmaceutical company, R & AMP; D dedicated to the development and marketing of senolytic compounds, food supplements and aging medications, age -related degenerative diseases and cancer.

322 similar entities Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Where science meets heart. Passionately committed to transforming the lives of people with genetically defined diseases. Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. …

60 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Making biology easier to engineer. At Ginkgo, we use biology to grow the future. Companies across industries leverage our platform to design, develop, and optimize products for a breadth of commercial applications. We help our partners grow key ingredients for vaccines, crops that rely less on fossil fuel-based fertilizers, plant-based meat that tastes like the real thing, materials for the next generation of circular fashion, and so much more. We know our unique experiences, ideas, and perspectives are essential to our success and enable us to make biology easier to engineer and ensure equitable distribution of the benefits of our …

73 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology SaaS

Celltrion is a leading biopharmaceutical company that specializes in research, development and manufacturing of innovative therapeutics. We are committed to delivering innovative and affordable medications to promote patients’ access to advanced therapies. We have been at the forefront of biotherapeutic development uncovering new ways of targeting the drivers of disease by creating next-generation biologics and small molecule products. For additional information on our guidelines, please visit: http://tinyurl.com/bdh9bxs9 To transform possibility into a reality by promoting the health and welfare of mankind. We thrive to meet the needs of people who previously had limited access to advanced therapeutics.

118 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

We have always invented for one and great purpose: life We have always invented for a single great purpose: life MSD, known in the United States and Canada with the name of Merck & Amp; Co., Inc., with headquarters in Kenilworth, (New Jersey, USA), is an American multinational leader in the pharmaceutical sector. For over 65 years in Italy and 130 in the world, we have revolutionized the therapeutic paradigms for dozens of pathologies through the discovery of over 200 innovative molecules. Our mission is to discover, develop, make innovative products and services available that save and improve the lives …

36 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. We are dedicated to making a meaningful impact in patients’ lives as well as the communities where we live and work. Our team is guided by our core values of collaboration, accountability, passion, respect, and integrity. Insmed is headquartered in Bridgewater, NJ, and has offices and research locations throughout the United States, Europe, and Japan. We are proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending four consecutive years as …

58 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

For humanity to thrive, we need transformative thinking in how vaccines and therapeutics are designed and produced. At Univercells, we believe in the power of small adaptations to drive big change. We embrace the spirit of evolution in everything we do. We are biotech innovators. We are scientists and entrepreneurs creating transformative platforms for the pharmaceutical and biotech industry, through technology, bioprocess know-how and entrepreneurial spirit. Biotechnology, mRNA, CDMO, and Services

88 similar entities Type: Startup Activities: manufacturing deeptech biotech Technologies: Synthetic Biology

Kyowa Kirin North America is a specialty pharmaceutical company dedicated to making a profound impact on patient lives. Kyowa Kirin is a global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines. We work on some of the hardest to treat diseases where need is high, and potential for life-changing impact is possible. The North America organization includes offices in Princeton, NJ; Toronto, Canada and a research facility in La Jolla, CA. Together, we work as a collaborative team to understand clinical needs and advance innovations that have a profound impact on patient lives. Our growth …

59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Developing novel IVD solutions Genz is a spin-off biotech company developing novel solutions from in vitro diagnostics to therapeutics. Our mission is to deliver a consistent stream of innovative, affordable, and accessible diagnostic solutions and make a remarkable impact on people’s lives. We’re focused on sustainable growth and addressing the world’s pressing health challenges; therefore, we’re able to create value for both our patients and our shareholders. To date, Genz developed 4 IVD diagnostic tests commercially legalized, attended International joint projects, partnered with top research centers in the world and published several scientific articles in international scientific journals. Biotechnology, Genetik …

161 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Better Access. Better Lives. Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars. Biopharmaceuticals, Research and Development, Biosimilars, Biotechnology, Pharmaceutical, Biogenerics, Health, Cell Line Development, Business Development, and Regulatory

232 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Leader in Clinical Diagnostic Testing & Biopharma Services. ***INC. 2024 Best Workplaces*** A leading diagnostic solutions company with five Medicare-covered tests for the lung cancer (oncology) healthcare continuum. Partnering with BioPharma companies with our unique portfolio of patented technologies, science, and processes. INC. 2024 Best Workplaces #proteomics #genomics #liquidbiopsy #bdsx #biodesix #lungcancer #biopharma #lifesciences #diagnostics Molecular Diagnostics, Predictive, Prognostic and Mutation Tests, Companion Diagnostics, Mass Spectrometry Analysis of Biological Samples, oncology, lung cancer, lung disease, cancer diagnostics, biomarkers, liquid biopsy, ddPCR, Non-Small Cell Lung Cancer, Lung Nodules, Nodule Management, Proteomics, Artificial Intelligence, Genomic Testing, Clinical Trials, Biopharma Services, genomics, and …

94 similar entities Type: SMB Activities: deeptech biotech Technologies: A.I. Synthetic Biology

Through conferences, community and market insights, we create partnerships that help advance the next pillar of medicine Phacilitate creates an environment where promising innovation can turn into the products that are changing the future of medicine. Recognised as the market leader in providing the life science sector with strategic insight, inspiration and unparalleled business networking, Phacilitate enables professionals to stay abreast of the issues driving life science innovation. #advancedtherapies #biotech #celltherapy #genetherapy Clinical Development, Cell Therapy, Gene Therapy, Oncology, Cancer, Precision Medicine, Biotech, Advanced Therapy, Biotechnology, and Life Sciences

196 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Research and innovation for patients is our lifeblood. So we contribute to a strong life science arena in Sweden. MSD Sweden's official LinkedIn. About us: http://www.msd.se/om-oss/ Life at MSD http://www.workforlife.com/ Follow us on Twitter under the name @MSDSverige We are on Youtube named @innovation Sweden Questions about MSD Medicines: medicalinfo@merck.com. Side effect reporting: pv.sweden@merck.com. Complaints: mmd.pqc.hh.sweden.chu@merck.com. Oncology, Diabetes, Hospital Specialty Care, Cardiovascular, Vaccines, and Women's Health

7 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Developing first-in-class solutions for unmet health and personal care needs Results through innovation. We are an innovative biotechnology group with two divisions. Our consumer health arm has commercial products for the personal care market addressing nail, skin, scalp and hair issues. NovaBiotics pharma division has advanced clinical-stage product candidates for medically unmet, life-limiting inflammatory, infectious and respiratory disease. Our highly disruptive solutions to personal care and health needs address significant global markets. biotechnology, biologics, infectious disease, and drug discovery & development

155 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Together for a healthier world Welcome to the Medice Health Family Based on our long -term tradition as a family business, we will noticeably help shape the future of medicine in the coming decade. We will be a leading global developer and provider of innovative, integrated and diverse health solutions. We are the Health Family for our patients, doctors, pharmacists, employees and partners. Nephrology, ADHD, urology, self -medication, prescription medicines, and digital health solutions

212 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Inventing for life We did great things in the past. Today we are doing great things for the future. Present in Portugal since 1970, MSD is, from the first moment, is faithful to the principles of innovation and continuous improvement in people's health and well-being. Being one of the largest pharmaceutical laboratories in the world and active partner in all health issues, MSD presents innovative solutions that contribute to the preservation and improvement of the lives of millions of people. For over a century, MSD has been discovered to solve some of the greatest challenges related to people's health and …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

Driven by innovation to contribute to a healthier and happier life We share a deep commitment to service and customer service, which, combined with our professionalism, helps us achieve our primary objective: giving a longer, healthier, happier life to society by offering safe and efficacious drugs. We are able to achieve this goal through research and analysis, as well as an understanding of the needs of our patients, professionals, distributors and institutional representatives. Medicamentos de prescripción, Nutraceuticos, and Productos farmacéuticos

153 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Delivering Excellence in Life Sciences Our purpose at Jenburkt Pharmaceuticals Ltd is to serve those in need of quality healthcare by bringing revolutionary, life-changing therapeutic solutions that are accessible to all. We believe in serving our patients – through them, we serve God, humanity and nation. Way back in the twentieth century, a visionary in the field of healthcare and philanthropic work – Shri Nandlal Mulji Bhuta laid the foundation for several companies. Today, with over 850+ committed team members across functions pan-India,we have 11 million+ prescriptions generated annually from 400,000+ pharmacies across the globe. Our organisation caters to large …

125 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Making the hope of early detection, a reality. Meet the team behind iBreastExam and cervAIcal! UE LifeSciences is a fast-growing, multi-national med-tech company bringing the promise of early detection of cancer to women globally. Our innovations have reached more than 250,000 women in 12 countries. We've grown revenue five-fold in the past three years with distribution in 10 countries and counting. And we've raised over $6 million in grants, international awards and equity capital! Our work is featured on platforms such as TED Talks and notable publications such as The New York Times, BBC World News, Forbes and others. Medical …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

The Cell Therapy Venture Builder MedXCell is a European cell therapy venture builder with a strong industrial mindset and a global perspective. Our focus is on technologies, techniques or novel applications in major diseases such as cancer, autoimmune, neurological and degenerative disorders. Established in 2018, we have offices in Switzerland, the EU (France) and the US (Cambridge, MA) and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development and funding capabilities. Biotechnology, Cell Therapy, Immunotherapy, NK Cells, Mesenchymal Stromal Cells, Immuno-oncology, and Osteoarthritis

410 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We Chase the Miracles of Science to Improve People’s Lives. Sanofi is an innovative, global biofarmaceutical company, which is guided by one goal, so that according to the slogan "We Chase the Miracles of Science to Improve People’s Lives", focusing on the power of science, change the world for the better. In 100 countries, the teams involved and talented work to change the face of medicine, making impossible possible. The company creates therapies and vaccines that save lives to millions of people around the world. We have a wide range of specialized medicinal products and services in many therapeutic areas …

3 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

DIANA Biotechnologies: Diversified Biotech We are leading Czech biotechnology company with a great innovative potential. We focus on the development of products based on our cutting edge research in the fields of molecular diagnostics and drug discovery. We have global ambitions and since our foundation in 2018 we already have achieved some of our goals. During COVID-19 pandemics, we were able to quickly develop one of the most innovative COVID-19 tests worldwide and we helped to increase the testing capacity of the whole country. As a result, we became the biggest Czech manufacturer of RT-PCR tests. Besides RT-PCR, we continue …

59 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Developing mRNA vaccines and therapeutics In September 2021, Sanofi acquired Translate Bio, a clinical-stage mRNA therapeutics company. This acquisition further accelerates Sanofi’s efforts to develop transformative vaccines and therapies using mRNA technology. It adds a critical pillar to the company’s mRNA Center of Excellence, which aims to unlock the potential of next-generation mRNA vaccines and other strategic areas such as immunology, oncology, and rare diseases. Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

“Inspiring Minds Advancing Science” Life Sciences BC is a not-for-profit, non-government, industry association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, advocacy, and promotion of our world-class science and industry. Biopharmaceuticals, Medical Devices, Medical Technologies, and Digital Health Care

321 similar entities Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology

Victorian industry association providing a focal point for connectivity and leadership across the Health Industry BioMelbourne Network’s mission is to foster the development of an advanced, innovation driven and sustainable health industry. As a for-purpose, industry led membership association, we encompass biotechnology, medical technology, pharmaceuticals and health innovation companies in the state of Victoria. We connect business, research, finance, health and government to support and promote the sector’s growth and facilitate the development and commercialisation of new drugs, devices, diagnostics and digital health technologies in Victoria. Since 2001, we have championed an environment that enables Victorian organisations to innovate, commercialise …

64 similar entities Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology

We Embrace the Challenge in Science Dompé farmaceutici is an international biopharmaceutical company involved in all activities of the pharmaceutical value chain, from research to development, production and marketing. As a long-established family company, we blend the stability that comes from our 130-year heritage with the agility and dynamism of a start-up. We can turn transformative breakthroughs into treatments because we have the right qualities and capabilities to deliver new drugs. Our 160,000 square meter R&D and production site in L’Aquila, Italy, is the heart of Dompé. Here, we conduct vital research, and produce and distribute our primary care and …

84 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Our mission is to discover new ways to improve and prolong people's lives. We base ourselves on scientific innovation to deal with the greatest challenges in the health sector: we discover and develop innovative treatments, identifying new ways to ensure that they reach as many people as possible. Novartis is based in Basel, Switzerland. The companies of our group employ around 125,000 collaborators and our products are available in 155 countries around the world. The ability to attract, cultivate and maintain talents is vital to continue developing innovative products that can offer patients the best results. Read the guidelines of …

61 similar entities Type: SMB Activities: biotech deeptech healthtech

Engineering Stroke Solutions ENGINEERING Stroke Solutions Acandis, founded in 2006, is a privately held German medical device company focused on the prevention and treatment of stroke. We have a passion for technology and our engineers are enthusiastic about creating solutions for unmet clinical needs to improve patient’s lives. We strive towards a comprehensive device portfolio and continuous development of products and services to improve stroke care for neurointerventionalists around the globe. The safety of our products has been demonstrated on the bench top and now the efficacy of those products is being proven in clinical trials. As a company we …

24 similar entities Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology

Our mission: patient: help inside. We use biotechnology to treat serious illnesses. Amgen was founded in 1980 and is now a globally leading independent biotechnology company, which is represented in almost 100 countries with around 27,000 employees. As a pioneer of biotechnology, we have four decades of experience in research, development and production of innovative human therapy. We focus on illnesses for which there are only a few or no therapy options. Every year, millions of patients with serious illnesses benefit from our therapies worldwide. Our medicines are used in nephrology, cardiology, hematology, oncology, bone health and in chronic inflammatory …

12 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Developing transformative solutions for patients with infectious diseases and other difficult to treat conditions Positive outcomes. Positive patient stories. These are our priorities at Paratek Pharmaceuticals. As a commercial-stage biopharmaceutical company, we develop transformative solutions for patients with infectious diseases and other difficult to treat conditions, and we believe that we have the right people, the right knowledge and the right drug to make a difference in patients’ lives. Our Mission To create positive stories for patients, physicians and caregivers based on trust and integrity. To accomplish this, our employees work hard to turn everyday decisions into everyday triumphs that …

39 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

We are a biopharmaceutical company dedicated?to transforming the future for underserved, global patient populations in bone health and related areas. We consistently embrace opportunities to improve the lives of our patients, their caregivers, our communities, our partners, and each other.

323 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

We are a global life science company committed to improving the health and well-being of people, animals and plants. As a global life science company, taking care of human, animal and plant life has been our priority for over 45 years. Today, we are a world leader in the production of heparin – the primary anticoagulant used to save approximately 100 million lives every year. We have also set the benchmark for the manufacture of APIs and functional ingredients for the pharmaceutical, nutraceutical, veterinary, animal nutrition and agricultural sectors. We work to innovate in human, animal, and plant health. Discover …

8 similar entities Type: SMB Activities: deeptech biotech